scispace - formally typeset
M

Michael Gleeson

Researcher at Loughborough University

Publications -  237
Citations -  19671

Michael Gleeson is an academic researcher from Loughborough University. The author has contributed to research in topics: Exercise physiology & Physical exercise. The author has an hindex of 65, co-authored 234 publications receiving 17603 citations. Previous affiliations of Michael Gleeson include Ruhr University Bochum & University of Aberdeen.

Papers
More filters
Journal ArticleDOI

Determination of the exercise intensity that elicits maximal fat oxidation

Juul Achten, +2 more
- 01 Jan 2002 - 
TL;DR: It is concluded that a protocol with 3-min stages and 35-W increments in work rate can be used to determine Fat(max).
Journal ArticleDOI

Prevention, diagnosis and treatment of the Overtraining Syndrome: ECSS Position Statement ‘Task Force’

Romain Meeusen, +5 more
- 21 Aug 2006 - 
TL;DR: A “check list” is proposed that might help the physicians and sport scientists to decide on the diagnosis of OTS and to exclude other possible causes of underperformance.
Journal Article

Position statement. Part two: Maintaining immune health.

Neil P. Walsh, +8 more
- 01 Jan 2011 - 
TL;DR: Inter-individual variability in immunocompetence, recovery, exercise capacity, non-training stress factors, and stress tolerance likely explains the different vulnerability of athletes to illness.
Journal ArticleDOI

Exercise, nutrition and immune function

Michael Gleeson, +2 more
- 01 Jan 2004 - 
TL;DR: To maintain immune function, athletes should eat a well-balanced diet sufficient to meet their energy requirements, and consuming 30–60 g carbohydrate during sustained intensive exercise attenuates rises in stress hormones such as cortisol and appears to limit the degree of exercise-induced immune depression.
Journal ArticleDOI

Markers to measure immunomodulation in human nutrition intervention studies

Ruud Albers, +10 more
- 01 Sep 2005 - 
TL;DR: It would be valuable to include several immune markers in addition to clinical outcome in future clinical trials in this area, as there is too little evidence that correlates markers with global health improvement.